Therapeutic effects and molecular mechanisms of quercetin in gynecological disorders

Xian Jian, Shi Chen, Chen Shi, Weichen Luo, Liyuan Zhou, Lili Jiang, Kuiran Liu
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2024 · vol. 173 , pp. 116418 · doi:10.1016/j.biopha.2024.116418 · PMID:38461683 · W4392626232
article OA: gold CC0
🔓 Open OA copy View on OpenAlex View on PubMed View at publisher

Abstract

Quercetin is a representative flavonoid that is widely present in fruits, herbs, and vegetables. It is also an important active core component in traditional Chinese medicines. As an important flavonoid, quercetin has various properties and exerts antioxidant, anti-inflammatory, and cardioprotective effects. The public interest in quercetin is increasing, and quercetin has been used to prevent or treat numerous of diseases, such as polycystic ovary syndrome (PCOS), cancer, autoimmune diseases and chronic cardiovascular diseases, in clinical experiments and animal studies due to its powerful antioxidant properties and minimal side effects. Quercetin exerts marked pharmacological effects on gynecological disorders; however, there have been no reviews about the potential health benefits of quercetin in the context of gynecological disorders, including PCOS, premature ovary failure (POF), endometriosis (EM), ovarian cancer (OC), cervical cancer (CC) and endometrial carcinoma (EC). Thus, this review aimed to summarize the biological effects of quercetin on gynecological disorders and its mechanisms.

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Polycystic Ovary Syndrome Polycystic Ovary Syndrome Polycystic Ovary Syndrome Polycystic Ovary Syndrome Polycystic Ovary Syndrome Quercetin Quercetin Quercetin Quercetin Quercetin Quercetin Animals Animals Animals Animals Antioxidants Antioxidants Antioxidants Antioxidants Antioxidants

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (100)

Source provenance

europepmc
last seen: 2026-06-11T06:19:48.454388+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-29T00:32:51.051821+00:00
License: CC0 · commercial use OK